141 related articles for article (PubMed ID: 14971289)
1. [Conservative treatment of chronic obstructive arterial disease with iloprost and physical training: assessment of results in 5 years of a study with 360 patients].
Apperti M; Masella A; Sabia D; Verde I
Ann Ital Chir; 2003; 74(4):453-7. PubMed ID: 14971289
[TBL] [Abstract][Full Text] [Related]
2. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (POAD). GISAP Study.
Int Angiol; 1994 Mar; 13(1):70-4. PubMed ID: 7521384
[TBL] [Abstract][Full Text] [Related]
4. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
5. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).
Meini S; De Franco V; Auteri A; Setacci C; Di Renzo M; Pieragalli D
Int Angiol; 2005 Mar; 24(1):64-9. PubMed ID: 15877001
[TBL] [Abstract][Full Text] [Related]
6. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
7. Iloprost infusion in diabetic patients with peripheral arterial occlusive disease and foot ulcers.
Mirenda F; La Spada M; Baccellieri D; Stilo F; Benedetto F; Spinelli F
Chir Ital; 2005; 57(6):731-5. PubMed ID: 16400768
[TBL] [Abstract][Full Text] [Related]
8. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
[TBL] [Abstract][Full Text] [Related]
9. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
[TBL] [Abstract][Full Text] [Related]
10. Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost.
Balzer K; Bechara G; Bisler H; Clevert HD; Diehm C; Heisig G; Held K; Mahfoud Y; Mörl H; Rücker G
Int Angiol; 1991; 10(4):229-32. PubMed ID: 1724669
[TBL] [Abstract][Full Text] [Related]
11. Prospects of prostanoid therapy. Preliminary results.
Castagno PL; Di Molfetta L; Merlo M; Barile G; Violato F; Buzzacchino A; Ponzio F
Minerva Cardioangiol; 2000; 48(1-2):9-18. PubMed ID: 10829583
[TBL] [Abstract][Full Text] [Related]
12. Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease Fontaine stage IV. DAWID Study Group.
Beischer W; Dembski JC; Gruss JD; Hofgärtner F; Horsch A; Horsch S; Kuhlmann HW; Loose DA; Mietaschk A; Schwilden ED; Spengel F; Spitzer W; Staben P; Stallkamp B; Stürzebecher CS; Tokhi M; von Bilderling P
Vasa; 1998 Feb; 27(1):15-9. PubMed ID: 9540427
[TBL] [Abstract][Full Text] [Related]
13. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
[TBL] [Abstract][Full Text] [Related]
14. [Modification of some prothrombotic indices after treatment with iloprost in arterial disease patients].
Ferlito S; Bonomo T; Costa R; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli M; Mazzone D
Minerva Cardioangiol; 1996 Dec; 44(12):645-8. PubMed ID: 9053818
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease.
Bozkurt AK; Köksal C; Demirbas MY; Erdoğan A; Rahman A; Demirkiliç U; Ustünsoy H; Metin G; Yillik L; Onol H; Cinar B; Karaçelik M; Erdinç I; Bolcal C; Sayin AG;
Int Angiol; 2006 Jun; 25(2):162-8. PubMed ID: 16763533
[TBL] [Abstract][Full Text] [Related]
16. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
Opitz CF; Wensel R; Winkler J; Halank M; Bruch L; Kleber FX; Höffken G; Anker SD; Negassa A; Felix SB; Hetzer R; Ewert R
Eur Heart J; 2005 Sep; 26(18):1895-902. PubMed ID: 15888496
[TBL] [Abstract][Full Text] [Related]
18. [A new infusion method for a prostacyclin analogue].
Pibiri L; Petruzzo P; Angius D; Ruiu G; Polo F; Rescigno A; Brotzu G
Minerva Cardioangiol; 1997 Dec; 45(12):621-5. PubMed ID: 9577128
[TBL] [Abstract][Full Text] [Related]
19. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol.
Milio G; Corrado E; Genova C; Amato C; Raimondi F; Almasio PL; Novo S
Rheumatology (Oxford); 2006 Aug; 45(8):999-1004. PubMed ID: 16484290
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of iloprost in patients with severe peripheral arterial occlusive disease.
Hildebrand M; Krause W; Oberender HA; Zurdel-Dillinger S; Jünger M; Bodenburg H
Eicosanoids; 1990; 3(3):145-8. PubMed ID: 1700723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]